April 29 Johnson & Johnson suspended
sale of devices used in fibroid surgery amid concerns about
their potential to spread a rare but deadly cancer, the Wall
Street Journal reported.
J&J was halting world-wide sale, distribution and promotion
of the tools called power morcellators but not permanently
pulling them from the market, the Journal said. (r.reuters.com/dyt88v)
The action follows a Food and Drug Administration advisory
on April 17 that discouraged doctors from using laparoscopic
power morcellators to remove fibroids - common but often painful
uterine growths - because of a risk of worsening an often-hidden
In a letter to customers, J&J wrote that it is waiting for
the regulator and the medical community to further clarify the
role of morcellation in fibroid treatment, the newspaper said.
Morcellators typically use long, tube-shaped blades to cut
and remove tissue through tiny incisions, helping patients avoid
open abdominal surgery associated with longer scars and
J&J spokeswoman Sheri Woodruff did not immediately respond
to an email seeking comment outside regular U.S. business hours.
(Reporting by Supriya Kurane and Arnab Sen in Bangalore;
Editing by Gopakumar Warrier)